Skip header and navigation

Narrow By

42 records – page 1 of 3.

24-hour urine collection : split daytime and nightime

https://libcat.nshealth.ca/en/permalink/chpams36496
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
1940
Available Online
View Pamphlet
Step-by-step instructions are provided to collect a 24 hour split urine sample. Locations for drop offs (24 hour access) are included.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Urine Specimen Collection
Specimen Handling
Subjects (LCSH)
Diagnostic specimens
Urine--Collection and preservation
Abstract
Step-by-step instructions are provided to collect a 24 hour split urine sample. Locations for drop offs (24 hour access) are included.
Responsibility
Prepared by: NSHA Renal Program
Pamphlet Number
1940
Less detail

Azathioprine for glomerulonephritis

https://libcat.nshealth.ca/en/permalink/chpams38301
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2024.
Pamphlet Number
2421
Available Online
View Pamphlet
Azathioprine is a medication that works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and how to store this medication.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Azathioprine
Glomerulonephritis
Immunosuppressive Agents
Subjects (LCSH)
Immunosuppressive agents
Kidneys--Diseases--Treatment
Abstract
Azathioprine is a medication that works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and how to store this medication.
Responsibility
Prepared by: Renal Program
Pamphlet Number
2421
Less detail

Bowel preparation for chronic kidney disease before colonoscopy

https://libcat.nshealth.ca/en/permalink/chpams35387
Nova Scotia Health Authority. Renal Program, Nova Scotia Health Authority. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
1475
Available Online
View Pamphlet
This pamphlet describes how to get ready for a colonoscopy if you have chronic kidney disease. Steps to prepare solutions on the day before your colonoscopy are listed. The day before your procedure and on the day of the test you should drink only clear liquids, and a suggested list is included. Remember not to eat any food or drink milk, or other liquids that are not clear, on the day before your colonoscopy or on the day of the test.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Nova Scotia Health Authority. Pharmacy Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Cathartics
Colonoscopy
Renal Insufficiency, Chronic
Subjects (LCSH)
Laxatives
Colonoscopy
Chronic renal failure
Specialty
Medications
Nephrology
Abstract
This pamphlet describes how to get ready for a colonoscopy if you have chronic kidney disease. Steps to prepare solutions on the day before your colonoscopy are listed. The day before your procedure and on the day of the test you should drink only clear liquids, and a suggested list is included. Remember not to eat any food or drink milk, or other liquids that are not clear, on the day before your colonoscopy or on the day of the test.
Responsibility
Prepared by: NSHA Renal Program Educators and Pharmacists
Pamphlet Number
1475
Less detail

Care of your arteriovenous fistula

https://libcat.nshealth.ca/en/permalink/chpams35622
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
0651
Available Online
View Pamphlet
An arteriovenous (AV) fistula gives access to your bloodstream for hemodialysis. It is made by joining an artery and a vein during surgery. This pamphlet explains when your fistula will be ready to use, what to expect after your surgery, how to care for your incision (cut), and how to exercise your fistula arm before and after surgery. It also includes information about what to do if you have bleeding at your fistula site, and a list of symptoms that need medical attention right away.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Central Venous Catheters
Renal Dialysis
Subjects (LCSH)
Hemodialysis
Specialty
Nephrology
Abstract
An arteriovenous (AV) fistula gives access to your bloodstream for hemodialysis. It is made by joining an artery and a vein during surgery. This pamphlet explains when your fistula will be ready to use, what to expect after your surgery, how to care for your incision (cut), and how to exercise your fistula arm before and after surgery. It also includes information about what to do if you have bleeding at your fistula site, and a list of symptoms that need medical attention right away.
Responsibility
Prepared by: Renal Program
Pamphlet Number
0651
Less detail

Care of your peritoneal dialysis catheter

https://libcat.nshealth.ca/en/permalink/chpams36677
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
0352
Available Online
View Pamphlet
This pamphlet reviews how to protect your peritoneal dialysis catheter. Information includes how to care for your incision (cut) or exit site after surgery and keeping your bowels regular. Information about when to call your VON or home care nurse is also given. The French version of this pamphlet 2098, "Prendre soin de votre cathéter de dialyse péritonéale", is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
English
Physical Description
1 electronic document (4 p.) : digital, PDF file
Subjects (MeSH)
Peritoneal Dialysis
Kidney Diseases - surgery
Subjects (LCSH)
Peritoneal access
Peritoneal dialysis
Specialty
Nephrology
Hematology
Abstract
This pamphlet reviews how to protect your peritoneal dialysis catheter. Information includes how to care for your incision (cut) or exit site after surgery and keeping your bowels regular. Information about when to call your VON or home care nurse is also given. The French version of this pamphlet 2098, "Prendre soin de votre cathéter de dialyse péritonéale", is also available.
Responsibility
Prepared by: NSHA Renal Program
Pamphlet Number
0352
Less detail

Cinacalcet (Sensipar) for secondary hyperparathyroidism in chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35371
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1465
Available Online
View Pamphlet
Secondary hyperparathyroidism is a condition that can be caused by chronic kidney disease (CKD). It happens when your kidneys cannot filter out waste products the right way. This leads to too much parathyroid hormone in your blood. Cinacalcet (sin-a-KAL-cet) is a medication that lowers the amount of parathyroid hormone in your blood. This will help to balance the amount of calcium and phosphorous in your blood. Sensipar® is the brand name for cinacalcet. This pamphlet explains how to take cinac…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Cinacalcet
Renal Insufficiency, Chronic - drug therapy
Hyperparathyroidism, Secondary - drug therapy
Subjects (LCSH)
Chronic renal failure
Hyperparathyroidism
Kidneys--Diseases--Treatment
Abstract
Secondary hyperparathyroidism is a condition that can be caused by chronic kidney disease (CKD). It happens when your kidneys cannot filter out waste products the right way. This leads to too much parathyroid hormone in your blood. Cinacalcet (sin-a-KAL-cet) is a medication that lowers the amount of parathyroid hormone in your blood. This will help to balance the amount of calcium and phosphorous in your blood. Sensipar® is the brand name for cinacalcet. This pamphlet explains how to take cinacalcet, possible side effects, and how to store this medication.
Notes
Previous title: Sensipar (Cinacalcet) to treat secondary hyperparathyroidism in chronic kidney disease
Previous title: Cinacalcet (Sensipar) to treat secondary hyperparathyroidism in chronic kidney disease (CKD)
Responsibility
Prepared by: Renal Program
Pamphlet Number
1465
Less detail

Cyclophosphamide for glomerulonephritis

https://libcat.nshealth.ca/en/permalink/chpams38303
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2024.
Pamphlet Number
2422
Available Online
View Pamphlet
Cyclophosphamide is a medication that works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and how to store this medication.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Cyclophosphamide
Glomerulonephritis
Immunosuppressive Agents
Subjects (LCSH)
Immunosuppressive agents
Kidneys--Diseases--Treatment
Abstract
Cyclophosphamide is a medication that works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and how to store this medication.
Responsibility
Prepared by: Renal Program
Pamphlet Number
2422
Less detail

Cyclosporine for glomerulonephritis

https://libcat.nshealth.ca/en/permalink/chpams38298
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2024.
Pamphlet Number
2418
Available Online
View Pamphlet
Cyclosporine is a medication that works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and how to store this medication.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Cyclosporine
Glomerulonephritis
Subjects (LCSH)
Immunosuppressive agents
Kidneys--Diseases--Treatment
Abstract
Cyclosporine is a medication that works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and how to store this medication.
Responsibility
Prepared by: Renal Program
Pamphlet Number
2418
Less detail

Dalteparin (Fragmin) to prevent clotting during hemodialysis

https://libcat.nshealth.ca/en/permalink/chpams35807
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
1760
Available Online
View Pamphlet
Dalteparin is a medication that is part of a group of drugs called blood thinners. Fragmin® is the brand name of dalteparin. During hemodialysis your blood passes through the dialysis blood lines and a dialyzer (artificial kidney), which can cause clots to form. Dalteparin stops clots from forming. This pamphlet explains how to take dalteparin, possible side effects, and symptoms that you should mention to your nurse.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Dalteparin
Renal Dialysis
Subjects (LCSH)
Hemodialysis
Blood--coagulation
Specialty
Nephrology
Abstract
Dalteparin is a medication that is part of a group of drugs called blood thinners. Fragmin® is the brand name of dalteparin. During hemodialysis your blood passes through the dialysis blood lines and a dialyzer (artificial kidney), which can cause clots to form. Dalteparin stops clots from forming. This pamphlet explains how to take dalteparin, possible side effects, and symptoms that you should mention to your nurse.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1760
Less detail

Day surgery peritoneal dialysis catheter insertion

https://libcat.nshealth.ca/en/permalink/chpams35158
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
1226
Available Online
View Pamphlet
This pamphlet reviews what to expect before, during and after surgery for the insertion of a peritoneal dialysis catheter. Information includes how to get your bowels ready for surgery, what to bring to the hospital on the day of surgery, care of your incision/exit site and keeping your bowels regular after surgery. Information about peritoneal dialysis teaching is also provided.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document (18 p.) : digital, PDF file
Subjects (MeSH)
Hospital admission
Peritoneal dialysis
Kidney Diseases - surgery
Preoperative Care
Postoperative Care
Subjects (LCSH)
Peritoneal access
Peritoneal dialysis
Preoperative care
Postoperative care
Specialty
Nephrology
Hematology
Abstract
This pamphlet reviews what to expect before, during and after surgery for the insertion of a peritoneal dialysis catheter. Information includes how to get your bowels ready for surgery, what to bring to the hospital on the day of surgery, care of your incision/exit site and keeping your bowels regular after surgery. Information about peritoneal dialysis teaching is also provided.
Responsibility
prepared by: NSHA Renal Program
Pamphlet Number
1226
Less detail

Erythropoieis-stimulating agents (ESAs) for people with chronic kidney disease (CKD) and active cancer or a history of cancer or stroke

https://libcat.nshealth.ca/en/permalink/chpams37446
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2024.
Pamphlet Number
2217
Available Online
View Pamphlet
If you have chronic kidney disease (CKD), your health care provider may order erythropoieis-stimulating agent (ESA) medications for you. This pamphlet explains the risks and benefits of ESAs if you have CKD and active cancer, or a history of cancer or stroke.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Renal insufficiency, chronic - complications
Anemia - drug therapy
Hematinics - therapeutic use
Neoplasms
Stroke
Subjects (LCSH)
Chronic renal failure--Complications
Hematopoietic growth factors
Renal anemia--Chemotherapy
Cancer
Cerebrovascular disease
Abstract
If you have chronic kidney disease (CKD), your health care provider may order erythropoieis-stimulating agent (ESA) medications for you. This pamphlet explains the risks and benefits of ESAs if you have CKD and active cancer, or a history of cancer or stroke.
Notes
Previous title: Erythropoieis-stimulating agents (ESAs) for chronic kidney disease (CKD) : with active cancer or a history of cancer or stroke
Responsibility
Prepared by: Renal Program
Pamphlet Number
2217
Less detail

Erythropoiesis-stimulating agent (ESA) therapy and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35406
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1493
Available Online
View Pamphlet
Erythropoiesis-stimulating agents (ESAs) are a group of medications that help take the place of a hormone called erythropoietin (EPO). People with chronic kidney disease (CKD) may not have enough EPO coming from their kidneys to tell their body to make more red blood cells. This pamphlet explains how to take and store this medication, and lists possible side effects.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal insufficiency, chronic - complications
Anemia - drug therapy
Subjects (LCSH)
Chronic renal failure--Complications
Renal anemia
Abstract
Erythropoiesis-stimulating agents (ESAs) are a group of medications that help take the place of a hormone called erythropoietin (EPO). People with chronic kidney disease (CKD) may not have enough EPO coming from their kidneys to tell their body to make more red blood cells. This pamphlet explains how to take and store this medication, and lists possible side effects.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1493
Less detail

Fer injectable et insuffisance rénale chronique (IRC)

https://libcat.nshealth.ca/en/permalink/chpams37473
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
2161
Available Online
View Pamphlet
Si votre corps manque d’oxygène en raison d’une carence en fer, il se peut que vous soyez fatigué ou essoufflé. On appelle cela l’anémie ferriprive. Beaucoup de patients atteints d’insuffisance rénale chronique (IRC) ou dialysés souffrent d’anémie, car ils n’ont pas assez de globules rouges, et le corps a besoin de fer pour les fabriquer. Prendre du fer par injection permet donc au corps d’avoir suffisamment de fer pour fabriquer de l’hémoglobine, c’est-à-dire la protéine qui transporte l’oxygè…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Alternate Title
Injectable iron and chronic kidney disease (CKD)
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Dialysis
Iron - therapeutic use
Kidney Diseases
Anemia, Iron-Deficiency
Subjects (LCSH)
Hemodialysis
Chronic renal failure--Complications
Iron deficiency anemia
Abstract
Si votre corps manque d’oxygène en raison d’une carence en fer, il se peut que vous soyez fatigué ou essoufflé. On appelle cela l’anémie ferriprive. Beaucoup de patients atteints d’insuffisance rénale chronique (IRC) ou dialysés souffrent d’anémie, car ils n’ont pas assez de globules rouges, et le corps a besoin de fer pour les fabriquer. Prendre du fer par injection permet donc au corps d’avoir suffisamment de fer pour fabriquer de l’hémoglobine, c’est-à-dire la protéine qui transporte l’oxygène. Ce dépliant explique comment prendre du fer injectable, ses effets possibles et comment le conserver.
This pamphlet is a French translation of the English pamphlet 1495, "Injectable Iron and Chronic Kidney Disease (CKD)". If your body is not getting enough oxygen due to lack of iron, you may feel tired or short of breath. This is called iron deficiency anemia. Many patients with chronic kidney disease (CKD), or who are on dialysis, have anemia because their red blood cells are low. The body needs iron to help make new red blood cells. Getting iron injections can help make sure that you have enough iron in your body to make the oxygen-carrying part (hemoglobin) of your red blood cells. This pamphlet explains how to take injectable iron, side effects to watch for, and instructions on how to store the medication.
Notes
Previous title: Injectable iron sucrose and chronic kidney disease
Responsibility
Prepared by: NSHA Renal Program
Pamphlet Number
2161
Less detail
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
0397
Available Online
View Pamphlet
A fistuloplasty is a non-surgical procedure used to open blocked or narrowed blood vessels in your fistula. The blood vessel is stretched with a special balloon. The pamphlet outlines who will do your procedure, where it is done, how long you will be at the hospital, how to get ready, and how the procedure is done. What happens after, risks, and a list of symptoms to watch for are provided.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Fistula - radiography
Balloon Occlusion
Radiography, Interventional - methods
Subjects (LCSH)
Fistula
Therapeutic embolization
Specialty
Nephrology
Abstract
A fistuloplasty is a non-surgical procedure used to open blocked or narrowed blood vessels in your fistula. The blood vessel is stretched with a special balloon. The pamphlet outlines who will do your procedure, where it is done, how long you will be at the hospital, how to get ready, and how the procedure is done. What happens after, risks, and a list of symptoms to watch for are provided.
Responsibility
Prepared by: Renal Program
Pamphlet Number
0397
Less detail

Hepatitis B vaccine and kidney disease

https://libcat.nshealth.ca/en/permalink/chpams36604
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1425
Available Online
View Pamphlet
The liver is an organ in your body that helps to break down and digest the food you eat, cleans your blood, and fights infection. Hepatitis B is a virus that attacks the liver. “Hepatitis” means swelling of the liver. Hepatitis B can cause serious liver problems, including liver damage, liver failure, and liver cancer. People with kidney disease who may need dialysis or a kidney transplant in the future, have a higher chance of getting Hepatitis B. The best way to prevent Hepatitis B is to get …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Hepatitis B - prevention & control
Kidney Diseases
Subjects (LCSH)
Hepatitis B vaccine
Kidneys--Diseases
Specialty
Nephrology
Abstract
The liver is an organ in your body that helps to break down and digest the food you eat, cleans your blood, and fights infection. Hepatitis B is a virus that attacks the liver. “Hepatitis” means swelling of the liver. Hepatitis B can cause serious liver problems, including liver damage, liver failure, and liver cancer. People with kidney disease who may need dialysis or a kidney transplant in the future, have a higher chance of getting Hepatitis B. The best way to prevent Hepatitis B is to get vaccinated. This pamphlet explains what the hepatitis B vaccine is, possible side effects, and who should not get the vaccine.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1425
Less detail

How to do a twin bag exchange

https://libcat.nshealth.ca/en/permalink/chpams34482
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
0633
Available Online
View Pamphlet
This pamphlet explains how to do your own peritoneal dialysis at home. It also explains how to deal with drain, fill, and mechanical problems. The Simplified Chinese version of this pamphlet 2214, is also available. The Russian version of this pamphlet 2379, is also available. The Vietnamese version of this pamphlet 2390, is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Peritoneal Dialysis
Subjects (LCSH)
Peritoneal dialysis
Specialty
Nephrology
Abstract
This pamphlet explains how to do your own peritoneal dialysis at home. It also explains how to deal with drain, fill, and mechanical problems. The Simplified Chinese version of this pamphlet 2214, is also available. The Russian version of this pamphlet 2379, is also available. The Vietnamese version of this pamphlet 2390, is also available.
Responsibility
Prepared by: Renal Program
Pamphlet Number
0633
Less detail

[How to do a twin bag exchange]

https://libcat.nshealth.ca/en/permalink/chpams37434
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
2214
Available Online
View Pamphlet
This pamphlet is a Simplified Chinese translation of the English pamphlet 0633, "How to do a Twin Bag™ Exchange". This pamphlet explains how to do your own peritoneal dialysis at home. It also explains how to deal with drain, fill, and mechanical problems.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
Simplified Chinese
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Peritoneal Dialysis
Subjects (LCSH)
Peritoneal dialysis
Specialty
Nephrology
Abstract
This pamphlet is a Simplified Chinese translation of the English pamphlet 0633, "How to do a Twin Bag™ Exchange". This pamphlet explains how to do your own peritoneal dialysis at home. It also explains how to deal with drain, fill, and mechanical problems.
Responsibility
Prepared by: Renal Program
Pamphlet Number
2214
Less detail

[How to do a twin bag exchange]

https://libcat.nshealth.ca/en/permalink/chpams38239
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
2379
Available Online
View Pamphlet
This pamphlet is a Russian translation of the English pamphlet 0633, "How to do a Twin Bag™ Exchange". This pamphlet explains how to do your own peritoneal dialysis at home. It also explains how to deal with drain, fill, and mechanical problems.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
Russian
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Peritoneal Dialysis
Subjects (LCSH)
Peritoneal dialysis
Specialty
Nephrology
Abstract
This pamphlet is a Russian translation of the English pamphlet 0633, "How to do a Twin Bag™ Exchange". This pamphlet explains how to do your own peritoneal dialysis at home. It also explains how to deal with drain, fill, and mechanical problems.
Responsibility
Prepared by: Renal Program
Pamphlet Number
2379
Less detail

[How to do a twin bag exchange]

https://libcat.nshealth.ca/en/permalink/chpams38262
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
2390
Available Online
View Pamphlet
This pamphlet is a Vietnamese translation of the English pamphlet 0633, "How to do a Twin Bag™ Exchange". This pamphlet explains how to do your own peritoneal dialysis at home. It also explains how to deal with drain, fill, and mechanical problems.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
Vietnamese
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Peritoneal Dialysis
Subjects (LCSH)
Peritoneal dialysis
Specialty
Nephrology
Abstract
This pamphlet is a Vietnamese translation of the English pamphlet 0633, "How to do a Twin Bag™ Exchange". This pamphlet explains how to do your own peritoneal dialysis at home. It also explains how to deal with drain, fill, and mechanical problems.
Responsibility
Prepared by: Renal Program
Pamphlet Number
2390
Less detail

Injectable iron and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35408
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1495
Available Online
View Pamphlet
Many people with chronic kidney disease (CKD), or who are on dialysis, have anemia because their red blood cells are low. The body needs iron to help make new red blood cells. This pamphlet explains how to take and store this medication, and lists possible side effects. The French version of this pamphlet 2161, "Fer injectable et insuffisance rénale chronique (IRC)," is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Dialysis
Iron - therapeutic use
Kidney Diseases
Anemia, Iron-Deficiency
Subjects (LCSH)
Hemodialysis
Chronic renal failure--Complications
Iron deficiency anemia
Abstract
Many people with chronic kidney disease (CKD), or who are on dialysis, have anemia because their red blood cells are low. The body needs iron to help make new red blood cells. This pamphlet explains how to take and store this medication, and lists possible side effects. The French version of this pamphlet 2161, "Fer injectable et insuffisance rénale chronique (IRC)," is also available.
Notes
Previous title: Injectable iron sucrose and chronic kidney disease
Responsibility
Prepared by: Renal Program
Pamphlet Number
1495
Less detail

42 records – page 1 of 3.